Match4Health

22–23 Sept 2023 | Larissa, Greece

Bernhard Nussbaumer

CBDO & Shareholder

ACMIT Gmbh

23 profile visits

General Manager focusing on business development and sales with proven track record in bringing innovations to the patients within the medtech ecosystem.

My organisation

ACMIT Gmbh

ACMIT Gmbh

Small Enterprise Company

Wiener Neustadt, Austria

ACMIT is an 13485 certified R&D-Center and incubator in the field of medical technology and offers: Medical technology research, R&D services all along the process chain from idea to clinical use of a medical device, Usability engineering and testing, Contract manufacturing (small series) of medical devices, Application-oriented anatomical models for medical training, surgical planning and medical device development, Incubator services for medical technology startups
Read more

About me

Bernhard Nussbaumer holds an MSc degree in electrical engineering from the Vienna University of Technology and also completed his MAS in business administration and engineering as well as his EMBA in entrepreneurial management in Vaduz (University of Liechtenstein). He has more than 20 years of experience in leading technology companies. Notably, as member of the board at Pantec Engineering AG, he established the startup business unit “Medical Laser” before leading Berliner Glas KGaA as general manager of the business unit “Medical Applications” to significant growth. In 2018, he joined ACMIT Gmbh as CBDO and is responsible for business development, strategy and sales. In 2023 he became shareholder of ACMIT Gmbh.

My organisation

ACMIT is an ISO 13485 certified R&D center in the field of medical technology offering R&D Services from idea to clinical use and incubator services for medical technology startups.

Social media

Skills

  • Business Development
  • Sales
  • R&D Services
  • medtech startups
  • medical technology
  • IP Design
  • patents
  • MDR
  • FDA
  • Regulatory

Interests

  • innovations for patients
  • medical technology
  • IP Design
  • startups
  • Investors